Notice No20190128-31Notice Date28 Jan 2019
CategoryCompany relatedSegmentEquity
SubjectClarification received from the company on news article

The Exchange, in order to verify certain news articles appearing in the various newspapers/ websites/ television channels and also to inform the members / investors with regard to the accuracy of the news articles, had sought clarification from the following company. Reply received from them is attached.

1.      Aurobindo Pharma Ltd (Scrip Code: 524804):

2.      DLF Ltd (Scrip Code: 532868):

For & On behalf of BSE Ltd



Yogendra Daxini

Jeevan Noronha

Assistant General Manager

Senior Manager



28 January, 2019

DLF Ltd_Reply.pdf
Aurobindo Pharma Ltd_Reply.pdf